Half E | Seppälä Labhttps://www.seppalalab.org/author/half-e/Half EHugo Blox Builder (https://hugoblox.com)enMon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.pngHalf Ehttps://www.seppalalab.org/author/half-e/Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revisionhttps://www.seppalalab.org/publication/zaffaroni-2024-updated/Mon, 01 Jan 2024 00:00:00 +0000https://www.seppalalab.org/publication/zaffaroni-2024-updated/Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statementhttps://www.seppalalab.org/publication/moller-2023-dominantly/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/moller-2023-dominantly/Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome databasehttps://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2023-mortality/